Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid-β Vaccine
Introduction: APP/PS1 double-transgenic mouse models of Alzheimer's disease (AD), which overexpress mutated forms of the gene for the human amyloid precursor protein (APP) and presenilin 1 (PS1), have provided robust neuropathological hallmarks of an AD-like pattern at early ages. This study ai...
Saved in:
Main Authors: | Ivan Carrera (Author), Ignacio Etcheverria (Author), Yi Li (Author), Lucia Fernandez-Novoa (Author), Valter Lombardi (Author), Carmen Vigo (Author), Hector H. Palacios (Author), Valery V. Benberin (Author), Ramon Cacabelos (Author), Gjumrakch Aliev (Author) |
---|---|
Format: | Book |
Published: |
University Library System, University of Pittsburgh,
2014-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model
by: Daniele Lana, et al.
Published: (2024) -
NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice
by: Yan Tan, et al.
Published: (2022) -
Gut dysbiosis aggravates cognitive deficits, amyloid pathology and lipid metabolism dysregulation in a transgenic mouse model of Alzheimer's disease
by: Chang Qu, et al.
Published: (2023) -
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer's Disease
by: Jeremy Koppel, et al.
Published: (2013) -
Lentivirus-Carried microRNA-195 Rescues Memory Deficits of Alzheimer's Disease Transgenic Mouse by Attenuating the Generation of Amyloid Plaques
by: Dan Su, et al.
Published: (2021)